Laddar...
Tumor homologous recombination deficiency assays: another step closer to clinical application?
Inherited and acquired defects in homologous recombination, a phenotype termed ‘BRCAness’, may lend to therapeutic exploitation in breast cancer. To this end, development and clinical evaluation of platforms to identify signatures of BRCAness are of immense interest. In this issue of Breast Cancer R...
Sparad:
| I publikationen: | Breast Cancer Res |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4448910/ https://ncbi.nlm.nih.gov/pubmed/25928813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0409-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|